1. Home
  2. NNAVW vs MRK Comparison

NNAVW vs MRK Comparison

Compare NNAVW & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNAVW
  • MRK
  • Stock Information
  • Founded
  • NNAVW 2007
  • MRK 2000
  • Country
  • NNAVW United States
  • MRK United States
  • Employees
  • NNAVW 96
  • MRK N/A
  • Industry
  • NNAVW Industrial Machinery/Components
  • MRK Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNAVW Industrials
  • MRK Health Care
  • Exchange
  • NNAVW Nasdaq
  • MRK Nasdaq
  • Market Cap
  • NNAVW N/A
  • MRK 198.5B
  • IPO Year
  • NNAVW N/A
  • MRK N/A
  • Fundamental
  • Price
  • NNAVW $6.49
  • MRK $83.23
  • Analyst Decision
  • NNAVW
  • MRK Buy
  • Analyst Count
  • NNAVW 0
  • MRK 15
  • Target Price
  • NNAVW N/A
  • MRK $113.71
  • AVG Volume (30 Days)
  • NNAVW 53.1K
  • MRK 18.2M
  • Earning Date
  • NNAVW 03-12-2025
  • MRK 07-29-2025
  • Dividend Yield
  • NNAVW N/A
  • MRK 3.98%
  • EPS Growth
  • NNAVW N/A
  • MRK 667.14
  • EPS
  • NNAVW N/A
  • MRK 6.88
  • Revenue
  • NNAVW $4,963,000.00
  • MRK $63,922,000,000.00
  • Revenue This Year
  • NNAVW N/A
  • MRK $2.42
  • Revenue Next Year
  • NNAVW N/A
  • MRK $5.77
  • P/E Ratio
  • NNAVW N/A
  • MRK $11.83
  • Revenue Growth
  • NNAVW 43.44
  • MRK 4.10
  • 52 Week Low
  • NNAVW $4.47
  • MRK $73.31
  • 52 Week High
  • NNAVW $4.70
  • MRK $129.93
  • Technical
  • Relative Strength Index (RSI)
  • NNAVW N/A
  • MRK 61.95
  • Support Level
  • NNAVW N/A
  • MRK $80.15
  • Resistance Level
  • NNAVW N/A
  • MRK $83.07
  • Average True Range (ATR)
  • NNAVW 0.00
  • MRK 1.91
  • MACD
  • NNAVW 0.00
  • MRK 0.28
  • Stochastic Oscillator
  • NNAVW 0.00
  • MRK 83.06

About NNAVW NextNav Inc. Warrant

NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Share on Social Networks: